Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
PLoS Negl Trop Dis. 2012;6(12):e1929. doi: 10.1371/journal.pntd.0001929. Epub 2012 Dec 6.
The objectives of this systematic review, commissioned by WHO, were to assess the frequency and severity of clinical manifestations of human brucellosis, in view of specifying a disability weight for a DALY calculation.
METHODS/PRINCIPAL FINDINGS: Thirty three databases were searched, with 2,385 articles published between January 1990-June 2010 identified as relating to human brucellosis. Fifty-seven studies were of sufficient quality for data extraction. Pooled proportions of cases with specific clinical manifestations were stratified by age category and sex and analysed using generalized linear mixed models. Data relating to duration of illness and risk factors were also extracted. Severe complications of brucellosis infection were not rare, with 1 case of endocarditis and 4 neurological cases per 100 patients. One in 10 men suffered from epididymo-orchitis. Debilitating conditions such as arthralgia, myalgia and back pain affected around half of the patients (65%, 47% and 45%, respectively). Given that 78% patients had fever, brucellosis poses a diagnostic challenge in malaria-endemic areas. Significant delays in appropriate diagnosis and treatment were the result of health service inadequacies and socioeconomic factors. Based on disability weights from the 2004 Global Burden of Disease Study, a disability weight of 0.150 is proposed as the first informed estimate for chronic, localised brucellosis and 0.190 for acute brucellosis.
This systematic review adds to the understanding of the global burden of brucellosis, one of the most common zoonoses worldwide. The severe, debilitating, and chronic impact of brucellosis is highlighted. Well designed epidemiological studies from regions lacking in data would allow a more complete understanding of the clinical manifestations of disease and exposure risks, and provide further evidence for policy-makers. As this is the first informed estimate of a disability weight for brucellosis, there is a need for further debate amongst brucellosis experts and a consensus to be reached.
本系统评价由世界卫生组织委托进行,旨在评估人类布鲁氏菌病的临床表现频率和严重程度,以便为 DALY 计算指定残疾权重。
方法/主要发现:检索了 33 个数据库,共确定了 1990 年 1 月至 2010 年 6 月期间发表的 2385 篇与人类布鲁氏菌病相关的文章。57 项研究质量足够,可以进行数据提取。按年龄组和性别分层分析了具有特定临床表现的病例的汇总比例,并使用广义线性混合模型进行分析。还提取了与疾病持续时间和危险因素相关的数据。布鲁氏菌病感染的严重并发症并不罕见,每 100 例患者中有 1 例心内膜炎和 4 例神经系统病例。10%的男性患有附睾炎或睾丸炎。关节痛、肌痛和背痛等使患者虚弱的症状分别影响了大约一半(65%、47%和 45%)的患者。由于 78%的患者有发热,因此布鲁氏菌病在疟疾流行地区构成了诊断挑战。由于卫生服务不足和社会经济因素,导致诊断和治疗的适当延迟。根据 2004 年全球疾病负担研究的残疾权重,建议将慢性局部布鲁氏菌病的残疾权重定为 0.150,急性布鲁氏菌病的残疾权重定为 0.190。
本系统评价增加了对布鲁氏菌病这一全球最常见的人畜共患病之一的全球负担的认识。突出了布鲁氏菌病的严重、使人虚弱和慢性影响。缺乏数据的地区开展设计良好的流行病学研究将有助于更全面地了解疾病的临床表现和暴露风险,并为决策者提供更多证据。由于这是布鲁氏菌病残疾权重的第一个知情估计,因此需要布鲁氏菌病专家进一步讨论并达成共识。